Yi-Lan Weng

Yi-Lan Weng

Assistant Professor of Neuroscience in Neurological Surgery
The Weng Lab studies how RNA modifications enforce immune self-tolerance and how their dysregulation generates pathological RNAs that activate innate sensors, driving neuroinflammation and neurodegeneration, including Alzheimer’s disease.
Program Affiliations
Research

We investigate how RNA modifications define immune self-tolerance and how their disruption gives rise to pathological RNAs that aberrantly activate innate immune pathways in the brain. Our work aims to uncover how failures in RNA regulation initiate and amplify neuroinflammation, ultimately contributing to neurodegenerative diseases such as Alzheimer’s disease.

Our research is organized into three integrated domains. First, we develop human disease reconstruction platforms to model early, causative events in neurodegeneration. By engineering systems that perturb nuclear protein homeostasis and RNA regulation, we recreate disease-relevant cellular states in human cells, enabling precise mechanistic dissection and scalable therapeutic discovery.

Second, we study RNA immunity and sensor biology. We focus on m⁶A-dependent RNA self-tolerance as a fundamental mechanism that distinguishes endogenous RNAs from immunogenic species. We investigate how dysregulation generates pathological RNAs that activate sensors such as ZBP1, and we define the structural and biochemical principles governing these interactions. This framework guides the development of RNA-based strategies to selectively block aberrant immune activation.

Third, we examine how immune activation propagates through the brain. We study how pathological RNAs and neuron-derived signals engage microglia and drive amplification programs, including membrane rupture–associated inflammatory responses. Our goal is to identify key control points that can be targeted to suppress harmful inflammation while preserving essential immune functions.

Biography

Yi-Lan Weng earned his bachelor’s degree in Chemistry and Life Science from National Tsing Hua University (Taiwan) in 1999 and his master’s degree in Biochemistry from National Yang-Ming University (Taiwan) in 2001. He received his PhD in Neuroscience at Case Western Reserve University (CWRU) in 2011 where he focused on cellular and molecular mechanisms of axon targeting and regeneration. 

While at CWRU, he helped to design a specific peptide that blocked protein tyrosine phosphatase-sigma signal transduction, successfully restored serotonergic innervation to the spinal cord in rats, and facilitated functional recovery of both locomotor and urinary systems following spinal cord injury. During his postdoctoral training at Johns Hopkins University, Dr. Weng developed a serial of innovative next-generation sequencing approaches and experimental methods to elucidate roles of DNA and RNA epigenetics in determining regenerative capacity. 

His findings have been published in the most prestigious journals, including Nature, Nature Neuroscience, and Neuron. In 2018, Dr. Weng joined the Center for Neuroregeneration at HMRI as an Assistant Professor. Dr. Weng’s research investigates the epitranscriptomic regulation of neuronal function.

Back to Top